Bulletin from Annual General Meeting in Recipharm AB (publ)
At the Annual General Meeting in Recipharm AB (publ) on May 10, 2017, the shareholders adopted the resolutions summarized below:· The presented annual report was adopted and the Board of Directors and the CEO were discharged for liability in respect of the financial year 2016. · The dividend of SEK 1.50 per share to the shareholders was approved and that the record day should be Friday, May 12, 2017. · The proposed fees to the Board of Directors, its committees and the auditor were approved. · Marianne Dicander Alexandersson, Lars Backsell, Carlos von Bonhorst Anders G.